Clinical Trials Browser

Phase 2 × Breast Neoplasms × cediranib × Clear all

NCT04090567 2026-03-05

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT02498613 2025-09-25

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Phase 2 Active not recruiting

122 enrolled 16 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00244881 2015-12-07

A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)

Phase 2 Completed

26 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male